COPD with sarcopenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Those who meet the above diagnostic criteria can be regarded as test cases. (2) The age is between 40 and 80 years old. (3) Patients with COPD in a stable period and no history of acute aggravation in the past 4 weeks. (4) Those who can complete the lung function measurement. (5) Those who have signed the informed consent form voluntarily participate in this experiment.
Exclusion criteria
Exclusion criteria: (1) The subject is pregnant breastfeeding or planning to become pregnant; 2) Active lung infection or past lung infection that has been treated with antibiotics and/or steroids before =4 weeks; (3) Combined with other known serious lung diseases including asthma active tuberculosis clinically significant bronchiectasis bronchial asthma lung cancer pneumothorax etc.; (4) Combined with severe primary diseases such as heart liver kidney and hematopoietic systems mental illness or any other researcher believes may threaten the patient's safety interfere with the evaluation or hinder the completion of the study; (5) Patients who are allergic to any research drugs or similar chemically classified drugs; (6) Patients who cannot successfully use a dry powder inhaler or cannot perform lung function measurement; (7) Those who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skeletal Muscle Mass Index,SMI);hand grip strength,HGS;pulmonary function;Walking speed; | — |
Secondary
| Measure | Time frame |
|---|---|
| St. Georges Respiratory Questionnaire SGRQ;modified Medical Research Council Dyspnea Scale,mMRC;6-minute walk test (6MWT);Clinical COPD Questionnaire,CCQ;COPD assessment test,CAT;BODE; | — |
Countries
China
Contacts
Hospital of Chengdu University of Traditional Chinese Medicine